Autolus Therapeutics plc Increase (Decrease) in Accrued Liabilities
Autolus Therapeutics plc (AUTL) reported Increase (Decrease) in Accrued Liabilities of $1.96 million for the 3-month period ending 2018-12-31, per its 20-F filed 2019-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2019-02-25
- Autolus Therapeutics plc increase (decrease) in accrued liabilities for the quarter ending 2018-12-31 was $1.96M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|
| 2018-12-31 | $1.96M 20-F · filed 2019-02-25 | |
| 2018-09-30 | $11.03M 20-F · filed 2019-02-25 | |
| 2017-09-30 | $1.09M 20-F · filed 2019-02-25 | |
| 2016-09-30 | $308.00K 20-F · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 |